LPA and atherosclerosis: Furthermore, given that Lp(a) levels are largely determined by genetic factors, with little influence from lifestyle modifications, cascade testing in patients with either premature ASCVD and/or known elevated Lp(a) may help prognosticate the CVD risk profiles of offspring and other family members and help direct lifetime risk reduction and primary prevention [27••, 30].